Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX)
CUSIP: 28036F105
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 109,183,673
- Total 13F shares
- 111,964,035
- Share change
- -6,779,965
- Total reported value
- $1,816,272,411
- Put/Call ratio
- 53%
- Price per share
- $16.22
- Number of holders
- 172
- Value change
- -$102,066,033
- Number of buys
- 75
- Number of sells
- 85
Quarterly Holders Quick Answers
What is CUSIP 28036F105?
CUSIP 28036F105 identifies EWTX - Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 28036F105:
Top shareholders of EWTX - Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13D/G
3/4/5
13F
|
Director, 10%+ Owner · Company |
14%
|
15,252,867
|
$234,894,152 | $0 | 09 May 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
13F
|
Company |
9.9%
|
10,428,437
|
$169,149,248 | $0 | 30 Sep 2025 | |
| Novo Holdings A/S |
3/4/5
13F
|
10%+ Owner · Company |
4.9%
from 13F
|
6,071,703
|
$95,781,722 | — | 14 Sep 2022 | |
| BAKER BROS. ADVISORS LP |
13F
13D/G
|
Company |
6.9%
from 13D/G
|
7,305,940
|
$95,780,873 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
5.5%
from 13D/G
|
6,781,046
|
$88,899,513 | — | 30 Jun 2025 | |
| JANUS HENDERSON GROUP PLC |
13D/G
13F
|
Company |
4.7%
|
4,979,331
|
$80,764,749 | -$8,499,572 | 30 Sep 2025 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
5.6%
|
6,142,344
|
$80,526,130 | — | 30 Jun 2025 | |
| BRAIDWELL LP |
13F
|
Company |
4.8%
|
5,210,831
|
$68,313,994 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.4%
|
4,841,500
|
$63,472,065 | — | 30 Jun 2025 | |
| PERCEPTIVE ADVISORS LLC |
13F
13D/G
|
Company |
4.4%
from 13D/G
|
4,639,949
|
$60,829,731 | — | 30 Jun 2025 | |
| Cormorant Asset Management, LP |
13F
|
Company |
3.9%
|
4,251,992
|
$55,743,615 | — | 30 Jun 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
2.9%
|
3,160,298
|
$41,431,507 | — | 30 Jun 2025 | |
| Bellevue Group AG |
13F
|
Company |
2.5%
|
2,775,997
|
$36,393,321 | — | 30 Jun 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.9%
|
2,101,781
|
$27,554,349 | — | 30 Jun 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.9%
|
2,067,320
|
$27,102,565 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
1,797,215
|
$23,564,445 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.6%
|
1,781,501
|
$23,355,478 | — | 30 Jun 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
1.6%
|
1,720,741
|
$22,558,915 | — | 30 Jun 2025 | |
| First Light Asset Management, LLC |
13F
|
Company |
1.6%
|
1,714,019
|
$22,470,789 | — | 30 Jun 2025 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
1.3%
|
1,379,068
|
$18,079,581 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
1%
|
1,096,863
|
$14,379,874 | — | 30 Jun 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.96%
|
1,048,936
|
$13,751,970 | — | 30 Jun 2025 | |
| New Leaf Venture Partners, L.L.C. |
13F
|
Company |
0.94%
|
1,030,161
|
$13,505,411 | — | 30 Jun 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.92%
|
1,000,000
|
$13,110,000 | — | 30 Jun 2025 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.89%
|
975,000
|
$12,782,250 | — | 30 Jun 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.84%
|
921,965
|
$12,086,961 | — | 30 Jun 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.72%
|
783,166
|
$10,267,325 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.67%
|
727,714
|
$9,540,337 | — | 30 Jun 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.66%
|
724,899
|
$9,503,426 | — | 30 Jun 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.66%
|
716,873
|
$9,398,205 | — | 30 Jun 2025 | |
| Peter A. Thompson |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
473,792
mixed-class rows
|
$8,933,533 | — | 16 Jun 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.59%
|
647,331
|
$8,486,509 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.58%
|
631,743
|
$8,282,150 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.55%
|
602,898
|
$7,903,993 | — | 30 Jun 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.55%
|
595,432
|
$7,806,114 | — | 30 Jun 2025 | |
| Foresite Capital Management VI LLC |
13F
|
Company |
0.54%
|
585,000
|
$7,669,350 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.53%
|
579,104
|
$7,592,053 | — | 30 Jun 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.52%
|
568,310
|
$7,450,544 | — | 30 Jun 2025 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.49%
|
539,730
|
$7,075,860 | — | 30 Jun 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.46%
|
499,917
|
$6,553,912 | — | 30 Jun 2025 | |
| Opaleye Management Inc. |
13F
|
Company |
0.45%
|
490,000
|
$6,423,900 | — | 30 Jun 2025 | |
| Kevin Koch |
3/4/5
|
President and CEO, Director |
—
mixed-class rows
|
981,899
mixed-class rows
|
$6,183,518 | -$177,122 | 12 Aug 2025 | |
| FMR LLC |
13F
|
Company |
0.43%
|
470,717
|
$6,171,106 | — | 30 Jun 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.41%
|
443,319
|
$5,811,912 | — | 30 Jun 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.41%
|
442,837
|
$5,805,593 | — | 30 Jun 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.4%
|
431,300
|
$5,654,343 | — | 30 Jun 2025 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.37%
|
405,478
|
$5,315,817 | — | 30 Jun 2025 | |
| Eversept Partners, LP |
13F
|
Company |
0.36%
|
392,739
|
$5,148,808 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.3%
|
325,249
|
$4,264,014 | — | 30 Jun 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.29%
|
317,173
|
$4,158,138 | — | 30 Jun 2025 |
Institutional Holders of Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX) as of Q3 2025
As of 30 Sep 2025,
Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX) was held by
172 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
111,964,035 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., BAKER BROS. ADVISORS LP, BlackRock, Inc., Paradigm Biocapital Advisors LP, NOVO HOLDINGS A/S, BRAIDWELL LP, JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, and Cormorant Asset Management, LP.
This page lists
172
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
177
Q3 2025 holders
172
Holder diff
-5
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.